D-0254-2026 Class II Ongoing
FDA drug recall D-0254-2026 was initiated by SpecGx, LLC on Dec 16, 2025 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets. The recall status is ongoing. Affected quantity: 287,988 Bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 14, 2026
- Initiation Date
- Dec 16, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 287,988 Bottles.
Product description
Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0523-01.
Reason for recall
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
Distribution pattern
Nationwide
Code information
Lot: 0523J23904, expires: 05/2027; 0523J24426, 0523J24427, expires: 06/2027.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0254-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026